Home > Share Market > Stocks > Lincoln pharmaceuticals > Financial Statements> LINCOLN Profit & Loss

Lincoln Pharmaceuticals Ltd Financial Statements

LINCOLN Profit and Loss

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 424 386 361 360
yoy growth (%) 9.75 7.18 0.10 (10)
Raw materials (198) (183) (193) (218)
As % of sales 46.60 47.30 53.40 60.40
Employee costs (61) (59) (51) (38)
As % of sales 14.30 15.20 14.20 10.40
Other costs (79) (79) (65) (58)
As % of sales 18.50 20.50 17.90 16.20
Operating profit 87.20 65.50 52.30 46.80
OPM 20.60 17 14.50 13
Depreciation (7.60) (7.30) (6.10) (5.50)
Interest expense (1.60) (2) (5.40) (6.70)
Other income 5.66 11 5.45 2.73
Profit before tax 83.70 67.20 46.20 37.30
Taxes (21) (16) (12) (9.20)
Tax rate (26) (23) (25) (25)
Minorities and other -- -- -- --
Adj. profit 62.20 51.40 34.60 28.10
Exceptional items -- -- -- --
Net profit 62.20 51.40 34.60 28.10
yoy growth (%) 21 48.60 23.10 18.80
NPM 14.70 13.30 9.60 7.81

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000